OPEN ACCESS pISSN 2234-3806
eISSN 2234-3814

Table. 1.

Table. 1.

Sample characteristics

Total (N = 40) Normal (N = 10) Mild leukopenia (N = 10) Moderate leukopenia (N = 10) Severe leukopenia (N = 10)
Age, median (IQR) 64 (33-76) 47 (33-71) 77 (64-78) 62 (62-73) 33 (33-65)
Male, N (%) 21 (52.5) 6 (60) 6 (60) 2 (20) 7 (70)
Diagnosis, N (%)
AML 18 (45) 3 (30) 1 (10) 7 (70) 7 (70)
Lymphoma* 5 (12.5) - 3 (30) 2 (20) -
PCM 4 (10) 1 (10) 1 (10) - 2 (20)
MDS 3 (7.5) - 3 (30) - -
ALL 1 (2.5) - - 1 (10) -
CML 1 (2.5) 1 (10) - - -
AA 1 (2.5) - - - 1 (10)
No hematologic diseases 7 (17.5) 5 (50) 2 (20) - -
WBC counts, median (IQR) 2,215 (610-4,863) 7,010 (5,708-7,798) 2,840 (2,615-3,400) 1,710 (1,125-1,930) 60 (50-190)
WBC differentials, N (%)
Five differentials 26 (65) 10 (100) 2 (20) 4 (40) 10 (100)
Blasts 3 (7.5) - 3 (30) - -
Immature granulocytes§ 8 (20) - 5 (50) 3 (30) -
nRBCs 1 (2.5) - 1 (10) - -
Lymphocytes, variant form 9 (22.5) - 6 (60) 3 (30) -

*Lymphoma included follicular lymphoma (N=3) and diffuse large B cell lymphoma (N=2); No hematologic diseases included bone marrow donors (N=2), liver disease (N=2), cardiac disease (N=2), and breast cancer (N=1); The number of WBC differentials included all numbers of five overlapping differentials, blasts, immature granulocytes, nRBC, and variant lymphocytes; §Immature granulocytes included promyelocytes, myelocytes, and metamyelocytes.

Abbreviations: N, number; IQR, interquartile range; AML, acute myeloid leukemia; ALL, acute lymphoblastic leukemia; PCM, plasma cell myeloma; MDS, myelodysplastic syndrome; CML, chronic myeloid leukemia; AA, aplastic anemia; WBC, white blood cell; nRBCs, nucleated red blood cells.

Ann Lab Med 2022;42:398~405 https://doi.org/10.3343/alm.2022.42.4.398

© Ann Lab Med